2 top blue chip ASX 200 shares rated as buys

Looking for blue chips? Check out these highly rated shares…

| More on:
woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you wanting to buy some blue chip ASX shares for your portfolio? Then you might want to check out the ones listed below.

These quality companies have been tipped as blue chips to buy. Here's what you need to know:

ResMed Inc. (ASX: RMD)

The first blue chip for investors to consider is ResMed. It is a medical device company with a focus on sleep disorders.

ResMed has continued to grow at a decent rate over the last 12 months despite the pandemic's negative impact on sleep disorder diagnoses and referrals. The good news is that with vaccines rolling out, referrals are expected to pick up again in FY 2022. And with one of its largest rivals recently having to recall an extremely popular sleep apnoea device, the company has been tipped to win further market share and continue its growth.

Looking further ahead, the company still has a very long runway for growth over the next decade. In fact, management has set itself a goal of improving 250 million lives in out-of-hospital healthcare in 2025. Helping it achieve this goal will be its high quality product portfolio, rapidly growing digital health ecosystem, and the growing awareness of sleep disorders and their impact on a person's overall health.

Earlier today, Macquarie upgraded the company's shares to an outperform rating with a $34.85 price target.

Sonic Healthcare Limited (ASX: SHL)

A second blue chip share to look at is Sonic Healthcare. It is a leading medical diagnostics company with operations across the world.

Unlike ResMed, Sonic has had the wind in its sails over the last 12 months. This led to the company reporting a 33% increase in half year revenue to $4.4 billion and a 166% jump in first half net profit to $678 million in February.

This was driven largely by strong demand for COVID-19 testing services. However, it is worth acknowledging that the rest of the business has been performing positively as well since trading conditions returned to relatively normal.

One broker that is a fan of the company is Credit Suisse. It currently has an outperform rating and $40.00 price target on Sonic's shares.

The broker is seeing signs of pent up demand for healthcare services after people delayed seeking healthcare during the pandemic. It expects Sonic to benefit from this, along with further COVID-19 testing in the near term.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Blue Chip Shares

2 safe ASX 200 shares for retirees to buy now

If you're nervous about the current volatility, then look at these shares that analysts rate as buys.

Read more »

a picture of the US federal reserve podium for making media announcements complete with US flag and federal reserve flag in the background and a large array of microphones set up.
Blue Chip Shares

Got $2,000? Buy these 2 ASX 200 stocks as Trump's Tariffs rock the markets

Analysts think these shares could be top picks following recent market volatility.

Read more »

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Blue Chip Shares

3 excellent Australian stocks to buy and hold for the next 10 years after the selloff

Analysts think these shares could be destined to deliver good returns for investors.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Blue Chip Shares

Named: The best ASX 200 blue chip shares to buy in March

There are good reasons why Bell Potter is tipping these as strong buys.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Blue Chip Shares

3 super strong ASX 200 shares to buy for your SMSF

Let's see why analysts are raving about these strong blue chips.

Read more »

Rolled up notes of Australia dollars from $5 to $100 notes
Blue Chip Shares

Top ASX 200 shares to buy with $1,000 this month

Brokers think these shares could be a good destination for a $1,000 investment in March.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Blue Chip Shares

Buy this ASX 100 stock with an 'undemanding valuation'

Goldman Sachs is feeling bullish about this blue chip. Let's find out why.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Blue Chip Shares

2 strong ASX 200 blue chip shares for your SMSF

Let's see why analysts are tipping these shares as a buy.

Read more »